ARTICLE | Distillery Therapeutics
Ophthalmic disease
June 13, 2018 6:18 PM UTC
In vitro, mouse and cell culture studies identified a mutant RHO-stabilizing compound that could help treat retinal degeneration and autosomal dominant retinitis pigmentosa (adRP). High throughput scr...
BCIQ Company Profiles
BCIQ Target Profiles